Cellectis (CLLS) Short-term Investments (2016 - 2026)

Cellectis' Short-term Investments history runs 11 years deep, the most recent figure standing at $150.8 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 29.96% year-over-year to $150.8 million; the TTM figure through Mar 2026 stood at $150.8 million (up 29.96% YoY), while the FY2025 annual figure was $147.1 million, up 25.69% from the prior year.
• Short-term Investments was $150.8 million for Q1 2026 at Cellectis, up from $147.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $150.8 million in Q1 2026 to a low of $499000.0 in Q1 2022.
• Historically, Short-term Investments has averaged $77.5 million across 5 years, with a median of $96.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments sank 97.29% in 2022, then jumped 11151.36% in 2024.
• A 5-year view of Short-term Investments shows it stood at $7.9 million in 2022, then soared by 595.59% to $55.0 million in 2023, then soared by 112.83% to $117.1 million in 2024, then climbed by 25.69% to $147.1 million in 2025, then climbed by 2.51% to $150.8 million in 2026.
• The last three Short-term Investments figures came in at $150.8 million (Q1 2026), $147.1 million (Q4 2025), and $140.0 million (Q3 2025), per Business Quant data.